Published in Am J Cardiol on May 01, 1995
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med (2005) 27.77
Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care (1999) 8.33
Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med (2003) 5.87
Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA (2012) 5.15
The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia (1998) 3.05
Blood pressure control for diabetic retinopathy. Cochrane Database Syst Rev (2015) 2.19
Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice. J Clin Invest (2005) 1.97
A genome-wide association study identifies a novel major locus for glycemic control in type 1 diabetes, as measured by both A1C and glucose. Diabetes (2009) 1.65
Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev (2011) 1.57
Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR). Diabetes Care (2010) 1.50
Best practice in primary care pathology: review 3. J Clin Pathol (2006) 1.45
Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care (2014) 1.42
Diabetes Remission after Nonsurgical Intensive Lifestyle Intervention in Obese Patients with Type 2 Diabetes. J Diabetes Res (2015) 1.39
Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions. Diabetes (2013) 1.31
Hypoglycemia, diabetes, and cardiovascular disease. Diabetes Technol Ther (2012) 1.30
Insulin is a stronger inducer of insulin resistance than hyperglycemia in mice with type 1 diabetes mellitus (T1DM). J Biol Chem (2009) 1.28
Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies. Vasc Health Risk Manag (2010) 1.24
Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial. Diabetes (1995) 1.24
Glycated haemoglobin (HbA1c) monitoring. BMJ (2006) 1.23
Predictive clinical parameters for the therapeutic efficacy of sitagliptin in korean type 2 diabetes mellitus. Diabetes Metab J (2011) 1.18
Aryl hydrocarbon receptor is activated by glucose and regulates the thrombospondin-1 gene promoter in endothelial cells. Circ Res (2008) 1.11
Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up. Diabetes Care (2016) 1.11
Diabetes and atherosclerosis: is there a role for hyperglycemia? J Lipid Res (2008) 1.09
Prevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type 1 diabetes. Diabetes Care (2009) 1.08
Diabetes and Cardiovascular Disease: Is intensive glucose control beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS, PROactive, and NICE-SUGAR. Wien Med Wochenschr (2010) 1.05
Clinical efficacy and patient satisfaction with U-500 insulin use. Diabetes Res Clin Pract (2010) 1.04
Why does diabetes increase atherosclerosis? I don't know! J Clin Invest (2004) 1.04
Hyperinsulinemia induces insulin resistance in dorsal root ganglion neurons. Endocrinology (2011) 1.01
Is glucose control important for prevention of cardiovascular disease in diabetes? Diabetes Care (2013) 1.01
Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis. Diabetes Rev (Alex) (1) 0.95
The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study. Diabetes Care (2007) 0.95
Diabetes portrayals in North American print media: a qualitative and quantitative analysis. Am J Public Health (2005) 0.95
The Diabetes Control and Complications Trial: the gift that keeps giving. Nat Rev Endocrinol (2009) 0.94
HbA1c and lower-extremity amputation risk in low-income patients with diabetes. Diabetes Care (2013) 0.93
Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes. Diabetes Care (1999) 0.93
A randomized, open-label, comparative crossover handling trial between two durable pens in patients with type 1 or 2 diabetes mellitus. J Diabetes Sci Technol (2011) 0.91
Characteristics of insured patients with persistent gaps in diabetes care services: the Translating Research into Action for Diabetes (TRIAD) study. Med Care (2010) 0.89
Peripheral arterial disease: Epidemiology, natural history, diagnosis and treatment. Int J Angiol (2007) 0.87
Common crossroads in diabetes management. Osteopath Med Prim Care (2008) 0.86
Current approach to the diagnosis and treatment of femoral-popliteal arterial disease. A systematic review. Curr Cardiol Rev (2009) 0.86
Pre-existing cardiovascular diseases and glycemic control in patients with type 2 diabetes mellitus in Europe: a matched cohort study. Cardiovasc Diabetol (2010) 0.85
Diabetes Dyslipidemia. Diabetes Ther (2016) 0.85
Differential effects of glyoxalase 1 overexpression on diabetic atherosclerosis and renal dysfunction in streptozotocin-treated, apolipoprotein E-deficient mice. Physiol Rep (2014) 0.83
Mitigating micro-and macro-vascular complications of diabetes beginning in adolescence. Vasc Health Risk Manag (2009) 0.83
Role of complement and complement regulatory proteins in the complications of diabetes. Endocr Rev (2015) 0.82
Diabetic vascular disease and the potential role of macrophage glucose metabolism. Ann Med (2011) 0.82
Challenges in the management of type 2 diabetes mellitus and cardiovascular risk factors in obese subjects: what is the evidence and what are the myths? Int J Endocrinol (2013) 0.82
Diabetes and atherogenesis. Heart (2004) 0.82
Challenges associated with peripheral arterial disease in women. Vasc Health Risk Manag (2014) 0.81
Present Insights on Cardiomyopathy in Diabetic Patients. Curr Diabetes Rev (2016) 0.81
Impact of a combined high cholesterol diet and high glucose environment on vasculature. PLoS One (2013) 0.81
Association of glycaemia with lipids in adults with type 1 diabetes: modification by dyslipidaemia medication. Diabetologia (2010) 0.80
Cross-sectional and longitudinal relationships of body mass index with glycemic control in children and adolescents with type 1 diabetes mellitus. Diabetes Res Clin Pract (2013) 0.80
Management of Type 1 Diabetes in Pregnancy. Curr Diab Rep (2016) 0.80
Targeting intensive versus conventional glycaemic control for type 1 diabetes mellitus: a systematic review with meta-analyses and trial sequential analyses of randomised clinical trials. BMJ Open (2014) 0.79
Glycemic Targets in Diabetes Care: Emerging Clarity after Accord. Trans Am Clin Climatol Assoc (2015) 0.79
Development of the OnTrack Diabetes Program. JMIR Res Protoc (2015) 0.79
Service usage and vascular complications in young adults with type 1 diabetes. BMC Endocr Disord (2014) 0.79
Follow the LEADER-Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results Trial. Diabetes Ther (2016) 0.79
Intermittent claudication. BMJ (2006) 0.79
Real-world utilization patterns and outcomes of colesevelam hcl in the ge electronic medical record. BMC Endocr Disord (2013) 0.79
Glycemia and cardiovascular risk: challenging evidence based medicine. Hippokratia (2011) 0.78
Celebrating 30 years of research accomplishments of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes (2013) 0.78
Change in adiposity minimally affects the lipid profile in youth with recent onset type 1 diabetes. Pediatr Diabetes (2014) 0.77
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. Curr Atheroscler Rep (2014) 0.76
Platelet thromboxane (11-dehydro-Thromboxane B2) and aspirin response in patients with diabetes and coronary artery disease. World J Diabetes (2014) 0.76
Combination therapy of miglitol and insulin in type 1 diabetes mellitus patients. J Diabetes Investig (2010) 0.76
7(th) Asian PAD Workshop. Ann Vasc Dis (2016) 0.75
Do the Effects of Secondary Prevention of Cardiovascular Events in PAD Patients Differ from Other Atherosclerotic Disease? Int J Mol Sci (2015) 0.75
Glucose control and cardiovascular disease: is it important? No. Diabetes Care (2009) 0.75
Advances in diabetes for the millennium: the heart and diabetes. MedGenMed (2004) 0.75
Long-term management of type 2 diabetes with glucagon-like peptide-1 receptor agonists. Diabetes Metab Syndr Obes (2017) 0.75
Association between Sickle Cell Trait and the Prevalence and Severity of Diabetic Retinopathy. PLoS One (2016) 0.75
Predictors of Dyslipidemia Over Time in Youth With Type 1 Diabetes: For the SEARCH for Diabetes in Youth Study. Diabetes Care (2017) 0.75
Correlates of overweight and obesity in 5529 adolescents with type 1 diabetes: The T1D Exchange Clinic Registry. Diabetes Res Clin Pract (2017) 0.75
Diabetes 2030: Insights from Yesterday, Today, and Future Trends. Popul Health Manag (2016) 0.75
Current status of managing diabetes mellitus in Korea. Korean J Intern Med (2016) 0.75
Molecular mechanisms of hyperglycemia and cardiovascular-related events in critically ill patients: rationale for the clinical benefits of insulin therapy. Clin Epidemiol (2010) 0.75